Prostate cancer is a major health concern with screening and early detection areas of controversy. In addition, genetic testing for prostate cancer is becoming more widely available. This presentation reviews the latest data on screening for prostate cancer and how to approach genetic testing for inherited prostate cancer risk.

Contact hours available until 4/7/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Conferences Committee Disclosures:
• Donna L. Thompson, MSN, CRNP, FNP-BC, CCCN-AP - Advisor Board for Domtar Industries
• Carolyn Stahlhut, CRNP - husband is employed as a contractor through Kelly Scientific at Jansen Pharmaceutical, also listed as a sub investigator for several clinical trials

Speakers Conflict of Interest Disclosure: There are no disclosures to declare.

Commercial Support and Sponsorship: There are no disclosures to delcare.

Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation.

The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
At the conclusion of this activity, the learner will be able to understand the basis of the controversy over prostate cancer screening, review current recommendations from national groups for both screening and genetic testing.